Trial Details
COMPLETEDBasic Information
| Clinical ID | c302 |
|---|---|
| Identifier | NCT03408249 |
| Trial Title | IBDoc Canadian User Performance Evaluation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DIAGNOSTIC_TEST: IBDoc calprotectin test|OTHER: questionnaire |
Participant Information
| Sponsor | Bühlmann Laboratories AG |
|---|---|
| City | Edmonton |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2017-05-05 |
|---|---|
| Primary Completion Date | 2017-08-22 |
| Completion Date | 2017-08-22 |